Your browser doesn't support javascript.
loading
Early Safety Findings Among Persons Aged ≥60 Years Who Received a Respiratory Syncytial Virus Vaccine - United States, May 3, 2023-April 14, 2024.
MMWR Morb Mortal Wkly Rep ; 73(21): 489-494, 2024 May 30.
Article in En | MEDLINE | ID: mdl-38814851

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Respiratory Syncytial Virus Infections / Respiratory Syncytial Virus Vaccines Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Country/Region as subject: America do norte Language: En Journal: MMWR Morb Mortal Wkly Rep / Morb. mort. wkly. rep. (Print) / Morbidity and mortality weekly report (Online) Year: 2024 Document type: Article Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Respiratory Syncytial Virus Infections / Respiratory Syncytial Virus Vaccines Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Country/Region as subject: America do norte Language: En Journal: MMWR Morb Mortal Wkly Rep / Morb. mort. wkly. rep. (Print) / Morbidity and mortality weekly report (Online) Year: 2024 Document type: Article Country of publication: